Contents of the Emergency Kit
The attached list was developed pursuant to 105CMR 150.008(E)(1), which states in part: “The contents of the kit shall be approved by the Department.”
The actual contents of the Emergency Kit are determined by each facility within the framework established by the Department of Public Health (DPH) through this guidance. The framework continues to allow facilities flexibility in choice of Schedule II-V medications, as summarized in the attached list. The list allows a choice of federally controlled analgesic and sedative/ anticonvulsant medication within Schedules II-V up to the maximum number of units allowed per facility, based on licensed bed capacity.
Each LTCF should develop its own “formulary” in conjunction with a single pharmacy provider of its own choosing and develop policies and procedures, including measures for controlled substance accountability and security, subject to review.
LTCFs are not required to have all items or the maximum quantity permitted. The previous list allowed no more than 43 analgesic units and 16 sedative/anticonvulsant units in each facility. The attached revised list bases the allowed maximum number of units for each medication group on the licensed bed capacity of facilities, in a 3:1 ratio of analgesics to sedative/anticonvulsants.
Each unit must be tamper evident/resistant, in an individually packaged, single dose form.
Schedule VI Medications
Facilities that wish to store Schedule VI controlled substances for emergency doses must comply with the requirements related to the procurement, storage, dispensing, administration, recording and disposal of these controlled substances. Further, storage of Schedule VI controlled substances must comply with facility policies and procedures, pursuant to 105 CMR 150.008, and with federal and state laws and regulations, and the use of these controlled substances must be monitored by the LTCF’s Quality Assurance and Assessment Committee.
Automated Dispensing Machines
DPH approves the use of automated dispensing devices by LTCFs in place of the traditional locked boxes for Schedule II-V controlled substances in emergency kits, provided all relevant regulations and guidance requirements are met.
The LTCF’s emergency kit practices, policies and procedures may be reviewed at any time by BHCSQ or DCP staff.
Questions or concerns regarding this Circular Letter should be directed to The Drug Control Program: email@example.com
The Division of Health Care Facilities Licensure and Certification: firstname.lastname@example.org.